Laboratory Medicine ›› 2024, Vol. 39 ›› Issue (3): 282-288.DOI: 10.3969/j.issn.1673-8640.2024.03.013
Previous Articles Next Articles
WANG Zhengquan, WU Zhengmu, LI Wen()
Received:
2023-04-26
Revised:
2023-09-11
Online:
2024-03-30
Published:
2024-04-24
CLC Number:
WANG Zhengquan, WU Zhengmu, LI Wen. Long-term biological variation of serum sex hormones during female follicular phase in Shanghai[J]. Laboratory Medicine, 2024, 39(3): 282-288.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2024.03.013
指标 | 检测均值/(ng·mL-1) | 重复性CV/% | 期间不精密度CV/% |
---|---|---|---|
AMH | |||
样本1 | 2.11 | 2.96 | 2.96 |
样本2 | 11.51 | 4.66 | 4.66 |
低值质控 | 1.04 | 3.19 | 3.19 |
高值质控 | 4.42 | 2.61 | 2.61 |
E2 | |||
样本1 | 40.99 | 4.04 | 4.87 |
样本2 | 747.52 | 1.23 | 1.61 |
低值质控 | 39.65 | 3.40 | 7.60 |
高值质控 | 118.13 | 1.78 | 1.78 |
FSH | |||
样本1 | 7.11 | 2.81 | 5.17 |
样本2 | 76.50 | 5.02 | 5.71 |
低值质控 | 15.24 | 3.40 | 4.02 |
高值质控 | 41.92 | 2.86 | 5.59 |
LH | |||
样本1 | 4.71 | 3.54 | 3.56 |
样本2 | 10.45 | 3.29 | 3.58 |
低值质控 | 9.79 | 3.20 | 4.38 |
高值质控 | 46.93 | 3.88 | 3.88 |
PRL | |||
样本1 | 8.05 | 2.46 | 3.99 |
样本2 | 21.74 | 4.15 | 4.87 |
低值质控 | 7.38 | 2.80 | 4.80 |
高值质控 | 20.01 | 1.86 | 4.91 |
Prog | |||
样本1 | 1.49 | 4.19 | 4.19 |
样本2 | 10.19 | 4.86 | 4.86 |
低值质控 | 4.28 | 4.69 | 4.79 |
高值质控 | 18.52 | 3.43 | 3.68 |
Testo | |||
样本1 | 3.42 | 2.13 | 6.02 |
样本2 | 7.10 | 1.42 | 2.69 |
低值质控 | 1.75 | 2.60 | 6.42 |
高值质控 | 4.38 | 2.29 | 5.41 |
指标 | 检测均值/(ng·mL-1) | 重复性CV/% | 期间不精密度CV/% |
---|---|---|---|
AMH | |||
样本1 | 2.11 | 2.96 | 2.96 |
样本2 | 11.51 | 4.66 | 4.66 |
低值质控 | 1.04 | 3.19 | 3.19 |
高值质控 | 4.42 | 2.61 | 2.61 |
E2 | |||
样本1 | 40.99 | 4.04 | 4.87 |
样本2 | 747.52 | 1.23 | 1.61 |
低值质控 | 39.65 | 3.40 | 7.60 |
高值质控 | 118.13 | 1.78 | 1.78 |
FSH | |||
样本1 | 7.11 | 2.81 | 5.17 |
样本2 | 76.50 | 5.02 | 5.71 |
低值质控 | 15.24 | 3.40 | 4.02 |
高值质控 | 41.92 | 2.86 | 5.59 |
LH | |||
样本1 | 4.71 | 3.54 | 3.56 |
样本2 | 10.45 | 3.29 | 3.58 |
低值质控 | 9.79 | 3.20 | 4.38 |
高值质控 | 46.93 | 3.88 | 3.88 |
PRL | |||
样本1 | 8.05 | 2.46 | 3.99 |
样本2 | 21.74 | 4.15 | 4.87 |
低值质控 | 7.38 | 2.80 | 4.80 |
高值质控 | 20.01 | 1.86 | 4.91 |
Prog | |||
样本1 | 1.49 | 4.19 | 4.19 |
样本2 | 10.19 | 4.86 | 4.86 |
低值质控 | 4.28 | 4.69 | 4.79 |
高值质控 | 18.52 | 3.43 | 3.68 |
Testo | |||
样本1 | 3.42 | 2.13 | 6.02 |
样本2 | 7.10 | 1.42 | 2.69 |
低值质控 | 1.75 | 2.60 | 6.42 |
高值质控 | 4.38 | 2.29 | 5.41 |
项目 | 第0个月测定值 | t值 | 显著性 | 规格上限 | 规格下限 | 稳定性 |
---|---|---|---|---|---|---|
AMH/(ng·mL-1) | ||||||
样本1 | 1.61 | -3.485 | 0.073 | 13个月 | ||
样本2 | 8.97 | -2.561 | 0.125 | 13个月 | ||
样本3 | 13.34 | -4.830 | 0.040 | 11.673 | 13个月 | |
E2/(pmol·L-1) | ||||||
样本1 | 160.33 | 2.452 | 0.134 | 13个月 | ||
样本2 | 313.59 | 0.792 | 0.511 | 13个月 | ||
样本3 | 1 366.97 | 0.614 | 0.602 | 13个月 | ||
FSH/(IU·L-1) | ||||||
样本1 | 1.77 | -2.126 | 0.167 | 13个月 | ||
样本2 | 31.83 | -17.913 | 0.003 | 27.851 | 13个月 | |
样本3 | 76.25 | -9.208 | 0.012 | 66.719 | 13个月 | |
LH/(IU·L-1) | ||||||
样本1 | 2.48 | 1.534 | 0.265 | 13个月 | ||
样本2 | 14.58 | 6.440 | 0.023 | 16.403 | 13个月 | |
样本3 | 37.87 | 0.457 | 0.692 | 13个月 | ||
PRL/(ng·mL-1) | ||||||
样本1 | 2.36 | -3.745 | 0.064 | 13个月 | ||
样本2 | 17.92 | -3.260 | 0.083 | 13个月 | ||
样本3 | 35.59 | -5.512 | 0.031 | 31.141 | 13个月 | |
Prog/(ng·mL-1) | ||||||
样本1 | 4.73 | -2.385 | 0.140 | 13个月 | ||
样本2 | 12.64 | -17.196 | 0.003 | 11.060 | 13个月 | |
样本3 | 34.63 | -10.111 | 0.010 | 30.301 | 13个月 | |
Testo/(nmol·L-1) | ||||||
样本1 | 0.45 | 19.919 | 0.003 | 0.506 | 13个月 | |
样本2 | 4.05 | 2.441 | 0.135 | 13个月 | ||
样本3 | 8.60 | 3.948 | 0.059 | 13个月 |
项目 | 第0个月测定值 | t值 | 显著性 | 规格上限 | 规格下限 | 稳定性 |
---|---|---|---|---|---|---|
AMH/(ng·mL-1) | ||||||
样本1 | 1.61 | -3.485 | 0.073 | 13个月 | ||
样本2 | 8.97 | -2.561 | 0.125 | 13个月 | ||
样本3 | 13.34 | -4.830 | 0.040 | 11.673 | 13个月 | |
E2/(pmol·L-1) | ||||||
样本1 | 160.33 | 2.452 | 0.134 | 13个月 | ||
样本2 | 313.59 | 0.792 | 0.511 | 13个月 | ||
样本3 | 1 366.97 | 0.614 | 0.602 | 13个月 | ||
FSH/(IU·L-1) | ||||||
样本1 | 1.77 | -2.126 | 0.167 | 13个月 | ||
样本2 | 31.83 | -17.913 | 0.003 | 27.851 | 13个月 | |
样本3 | 76.25 | -9.208 | 0.012 | 66.719 | 13个月 | |
LH/(IU·L-1) | ||||||
样本1 | 2.48 | 1.534 | 0.265 | 13个月 | ||
样本2 | 14.58 | 6.440 | 0.023 | 16.403 | 13个月 | |
样本3 | 37.87 | 0.457 | 0.692 | 13个月 | ||
PRL/(ng·mL-1) | ||||||
样本1 | 2.36 | -3.745 | 0.064 | 13个月 | ||
样本2 | 17.92 | -3.260 | 0.083 | 13个月 | ||
样本3 | 35.59 | -5.512 | 0.031 | 31.141 | 13个月 | |
Prog/(ng·mL-1) | ||||||
样本1 | 4.73 | -2.385 | 0.140 | 13个月 | ||
样本2 | 12.64 | -17.196 | 0.003 | 11.060 | 13个月 | |
样本3 | 34.63 | -10.111 | 0.010 | 30.301 | 13个月 | |
Testo/(nmol·L-1) | ||||||
样本1 | 0.45 | 19.919 | 0.003 | 0.506 | 13个月 | |
样本2 | 4.05 | 2.441 | 0.135 | 13个月 | ||
样本3 | 8.60 | 3.948 | 0.059 | 13个月 |
指标 | 单位 | 均值 | 绝对范围 | CVA/%① | 本研究 | EFLM数据库 | |||
---|---|---|---|---|---|---|---|---|---|
CVI/% | CVG/% | CVI/% | CVG/% | ||||||
AMH | ng·mL-1 | 3.36 | 1.68~6.78 | 2.91 | 15.52* | 22.51 | 19.2 | ||
E2 | pmol·L-1 | 296.76 | 92.84~479.72 | 5.52 | 20.99* | 21.22* | 15.0 | 13.0 | |
FSH | IU·L-1 | 4.21 | 1.76~8.52 | 4.87 | 13.90 | 33.48* | 12.4 | 42.1 | |
LH | IU·L-1 | 4.42 | 2.30~7.91 | 4.14 | 12.38* | 25.37* | 22.8 | 30.8 | |
PRL | ng·mL-1 | 13.81 | 2.55~29.52 | 4.86 | 15.92* | 32.02* | 29.5 | 43.0 | |
Prog | ng·mL-1 | 0.82 | 0.25~1.83 | 4.27 | 19.62 | 37.40 | 18.5 | 39.7 | |
Testo | nmol·L-1 | 1.47 | 0.74~2.21 | 5.94 | 13.85 | 24.73 | 12.5 | 21.4 |
指标 | 单位 | 均值 | 绝对范围 | CVA/%① | 本研究 | EFLM数据库 | |||
---|---|---|---|---|---|---|---|---|---|
CVI/% | CVG/% | CVI/% | CVG/% | ||||||
AMH | ng·mL-1 | 3.36 | 1.68~6.78 | 2.91 | 15.52* | 22.51 | 19.2 | ||
E2 | pmol·L-1 | 296.76 | 92.84~479.72 | 5.52 | 20.99* | 21.22* | 15.0 | 13.0 | |
FSH | IU·L-1 | 4.21 | 1.76~8.52 | 4.87 | 13.90 | 33.48* | 12.4 | 42.1 | |
LH | IU·L-1 | 4.42 | 2.30~7.91 | 4.14 | 12.38* | 25.37* | 22.8 | 30.8 | |
PRL | ng·mL-1 | 13.81 | 2.55~29.52 | 4.86 | 15.92* | 32.02* | 29.5 | 43.0 | |
Prog | ng·mL-1 | 0.82 | 0.25~1.83 | 4.27 | 19.62 | 37.40 | 18.5 | 39.7 | |
Testo | nmol·L-1 | 1.47 | 0.74~2.21 | 5.94 | 13.85 | 24.73 | 12.5 | 21.4 |
项目 | AMH | E2 | FSH | LH | PRL | Prog | Testo |
---|---|---|---|---|---|---|---|
允许不精密度 | |||||||
最佳 | 3.88 | 5.25 | 3.48 | 3.10 | 3.98 | 4.91 | 3.46 |
适当 | 7.76 | 10.50 | 6.95 | 6.19 | 7.96 | 9.81 | 6.93 |
最低 | 11.64 | 15.74 | 10.43 | 9.29 | 11.94 | 14.72 | 10.39 |
允许偏差 | |||||||
最佳 | 3.42 | 3.73 | 3.46 | 3.53 | 4.47 | 5.28 | 3.54 |
适当 | 6.84 | 7.46 | 6.93 | 7.06 | 8.94 | 10.56 | 7.09 |
最低 | 10.25 | 11.19 | 10.39 | 10.59 | 13.41 | 15.84 | 10.63 |
允许总误差 | |||||||
最佳 | 9.82 | 12.39 | 9.20 | 8.64 | 11.04 | 13.37 | 9.26 |
适当 | 19.64 | 24.78 | 18.40 | 17.27 | 22.07 | 26.74 | 18.51 |
最低 | 29.46 | 37.17 | 27.60 | 25.91 | 33.11 | 40.12 | 27.77 |
项目 | AMH | E2 | FSH | LH | PRL | Prog | Testo |
---|---|---|---|---|---|---|---|
允许不精密度 | |||||||
最佳 | 3.88 | 5.25 | 3.48 | 3.10 | 3.98 | 4.91 | 3.46 |
适当 | 7.76 | 10.50 | 6.95 | 6.19 | 7.96 | 9.81 | 6.93 |
最低 | 11.64 | 15.74 | 10.43 | 9.29 | 11.94 | 14.72 | 10.39 |
允许偏差 | |||||||
最佳 | 3.42 | 3.73 | 3.46 | 3.53 | 4.47 | 5.28 | 3.54 |
适当 | 6.84 | 7.46 | 6.93 | 7.06 | 8.94 | 10.56 | 7.09 |
最低 | 10.25 | 11.19 | 10.39 | 10.59 | 13.41 | 15.84 | 10.63 |
允许总误差 | |||||||
最佳 | 9.82 | 12.39 | 9.20 | 8.64 | 11.04 | 13.37 | 9.26 |
适当 | 19.64 | 24.78 | 18.40 | 17.27 | 22.07 | 26.74 | 18.51 |
最低 | 29.46 | 37.17 | 27.60 | 25.91 | 33.11 | 40.12 | 27.77 |
[1] |
王瑛, 蒋筠斐, 钟政荣. 健康成人23项常规检验项目的生物学变异分析[J]. 临床输血与检验, 2020, 22(1):39-45.
DOI |
[2] |
COSKUN A, ZAREPOUR A, ZARRABI A. Physiological rhythms and biological variation of biomolecules:the road to personalized laboratory medicine[J]. Int J Mol Sci, 2023, 24(7):6275.
DOI URL |
[3] |
CHEN J, KIM Y C, JUNG Y C, et al. Scanning the human genome at kilobase resolution[J]. Genome Res, 2018, 18(5):751-762.
DOI URL |
[4] | ALI M A, HOSSAIN M S, JULIANA F M, et al. Evaluation of biological variation of different clinical laboratory analytes in the blood of healthy subjects[J]. Cureus, 2023, 15(3):e36242. |
[5] | FRASER C G. Biological variation:from principles to practice[M]. Washington(WA): AACC Press, 2001. |
[6] |
HILDERINK J M, VAN DER LINDEN N, KIMENAI D M, et al. Biological variation of creatinine,cystatin C,and eGFR over 24 hours[J]. Clin Chem, 2018, 64(5):851-860.
DOI URL |
[7] |
CAROBENE A, GUERRA E, LOCATELLI M, et al. Biological variation estimates for prostate specific antigen from the European biological variation study;consequences for diagnosis and monitoring of prostate cancer[J]. Clin Chim Acta, 2018, 486:185-191.
DOI URL |
[8] |
RØRAAS T, PETERSEN P H, SANDBERG S. Confidence intervals and power calculations for within-person biological variation:effect of analytical imprecision,number of replicates,number of samples,and number of individuals[J]. Clin Chem, 2012, 58:1306-1313.
DOI URL |
[9] | 黄健. 抗缪勒氏管激素与性激素联合检测在多囊卵巢综合征中的诊断价值[J]. 临床医药实践, 2023, 32(2):104-107. |
[10] | 沈君, 胡宁宁. 多囊卵巢综合征血流动力学检查及其与血清性激素水平的相关性分析[J]. 现代医学与健康研究(电子版), 2022, 6(23):42-44. |
[11] | 王攀, 申庆文, 叶国柳. 血清25羟维生素D3、糖类抗原125、睾酮在子宫内膜癌中的表达及其联合检测的临床价值[J]. 安徽医药, 2022, 26(12):2434-2438. |
[12] |
VAN DER VEEN A, VAN FAASSEN M, DE JONG W H A, et al. Development and validation of a LC-MS/MS method for the establishment of reference intervals and biological variation for five plasma steroid hormones[J]. Clin Biochem, 2019, 68:15-23.
DOI PMID |
[13] |
ANDERSSON A M, CARLSEN E, PETERSEN J H, et al. Variation in levels of serum inhibin B,testosterone,estradiol,luteinizing hormone,follicle-stimulating hormone,and sex hormone-binding globulin in monthly samples from healthy men during a 17-month period:possible effects of seasons[J]. J Clin Endocrinol Metab, 2003, 88(2):932-937.
DOI URL |
[14] | 中华人民共和国国家卫生健康委员会. WS/T 645.2—2018 临床常用免疫学检验项目参考区间第2部分:血清甲胎蛋白、癌胚抗原、糖链抗原19-9、糖链抗原15-3、糖链抗原125[S]. 北京: 中华人民共和国国家卫生健康委员会, 2018. |
[15] | 中华人民共和国国家卫生健康委员会. WS/T 404.4—2018 临床常用生化检验项目参考区间第4部分:血清总胆红素、直接胆红素[S]. 北京: 中华人民共和国国家卫生健康委员会, 2018. |
[16] | Clinical and Laboratory Standards Institute. Evaluation of precision of quantitative measurement procedures[S]. EP05-A3,CLSI, 2014. |
[17] | Clinical and Laboratory Standards Institute. Evaluation of stability of in vitro diagnostic reagents[S]. EP25-A,CLSI, 2009. |
[18] |
KLEE G G. Establishment of outcome-related analytic performanee goals[J]. Clin Chem, 2010, 56(5):714-722.
DOI URL |
[19] | AARSAND A K, FERNANDEZ-CALLE P, WEBSTER C, et al. The EFLM biological variation database[Z]. 2022. |
[20] | 吴际. 血液学检验常规项目生物学变异的研究[D]. 北京: 北京协和医学院, 2013. |
[21] |
FRASER C G. The 1999 Stockholm consensus conference on quality specifications in laboratory medicine[J]. Clin Chem Lab Med, 2015, 53(6):837-840.
DOI PMID |
[22] | HORVATH A R, BOSSUYT P M, SANDBERG S, et al. Setting analytical performance specifications based on outcome studies-is it possible[J]. Clin Chem Lab Med, 2015, 53(6):841-848. |
[23] |
HADLOW N, BROWN S J, HABIB A, et al. Quantifying the intra individual variation of antimüllerian hormone in the ovarian cycle[J]. Fertil Steril, 2016, 106(5):1230-1237.
DOI URL |
[24] |
RICÓS C, ARBÓS M A. Quality goals for hormone testing[J]. Ann Clin Biochem, 1990, 27(Pt 4):353-358.
DOI URL |
[1] | WANG Wei, ZHANG Zhixin, ZHANG Chuanbao, ZHOU Weiyan, WANG Zhiguo. Establishment of allowable total error,allowable imprecision and allowable bias for 22 endocrine analytes [J]. Laboratory Medicine, 2023, 38(8): 707-712. |
[2] | MIAO Yingbo, ZHAO Qiang, SONG Ying, ZHU Peichao, ZHOU Wei, XU Chong. Research on performance specification of thrombelastogram [J]. Laboratory Medicine, 2022, 37(7): 680-683. |
[3] | YANG Xue, JU Yi, OU Yuanzhu, ZHU Yuqing, XU Chong, JIANG Lingli, WANG Qing, ZHOU Jing. Analysis on the results of external quality assessment of mutual recognition quantitative items in Shanghai [J]. Laboratory Medicine, 2022, 37(12): 1129-1134. |
[4] | MIAO Yingbo, SONG Ying, ZHAO Qiang, ZHU Peichao, ZHOU Wei, WANG Qing, XU Chong. Performance specification for differential blood count project in Shanghai [J]. Laboratory Medicine, 2021, 36(12): 1274-1276. |
[5] | TANG Lin, ZHANG Xiaojing, TANG Zhenhua. Investigation of gestational anemia in Shanghai,2016 [J]. Laboratory Medicine, 2020, 35(2): 116-119. |
[6] | CAO Hui, XIA Wanbao, DING Xiali, LIU Jun, PENG Jinghong. Analysis of the characteristics of sexually transmitted disease infection in Songjiang District of Shanghai [J]. Laboratory Medicine, 2019, 34(9): 804-807. |
[7] | LIU Wenbin, JU Yi, TANG Liping, WANG Meijuan, OU Yuanzhu, YU Xiaoxuan, LI Qing. IFCC Secondary Reference Measurement Procedure for 4 HbA1c determination systems [J]. Laboratory Medicine, 2019, 34(5): 443-446. |
[8] | ZHANG Li, HE Yao. Comparative study on reference change values and reference change factors of tumor markers [J]. Laboratory Medicine, 2019, 34(11): 991-993. |
[9] | CAI Jinfeng, ZHANG Guihong, ZHENG Jianghua. Isolation and drug resistance of Mycobacterium from AIDS patients in Shanghai from 2012 to 2016 [J]. Laboratory Medicine, 2018, 33(12): 1071-1075. |
[10] | WANG Juan, LI Yindi. Relationship of maternal sex hormones,IGF-1 and 25(OH)D in serum during pregnancy [J]. Laboratory Medicine, 2017, 32(11): 970-974. |
[11] | TANG Liping, OU Yuanzhu, WANG Meijuan, LIU Wenbin, YU Xiaoxuan, JU Yi. Analysis on the results of external quality assessment of cystatin C in Shanghai [J]. Laboratory Medicine, 2016, 31(8): 713-717. |
[12] | FENG Renfeng. Consensus on the analysis quality goal of clinical laboratories(Ⅱ) [J]. Laboratory Medicine, 2016, 31(2): 83-86. |
[13] | CHEN Hongyan, QIU Haiwen. Investigation on the establishment of reference change values for test results [J]. Laboratory Medicine, 2015, 30(5): 529-532. |
[14] | LI Guohua, WANG Wei, HE Falin, ZHONG Kun, ZHANG Yan, ZHAO Yan, WANG Zhiguo.. Investigation and analysis on the coefficients of variation of internal quality control for dry chemistry tests in China [J]. Laboratory Medicine, 2015, 30(4): 381-385. |
[15] | LU Gang, GAO Shejun, JU Yingbo.. Methodology evaluation and biological variation research of enzymatic colorimetric assay for the determination of serum free fatty acid [J]. , 2014, 29(2): 143-147. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||